N-halogenated amino acid formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2684098

The present invention relates to a method for treating a tissue infection comprising contacting the infected tissue with a pharmaceutically effective amount of a formulation comprising a N-halogenated amino acid and a phase transfer agent. This specification also describes a formulation having antimicrobial activity comprising a N-halogenated amino acid and a phase transfer agent.

La présente invention concerne un procédé pour traiter une infection tissulaire qui consiste à mettre en contact les tissus infectés avec un dose efficace sur le plan pharmaceutique d'une formulation comprenant un acide aminé N-halogéné et un agent de transfert de phase. L'invention concerne également une formulation présentant une activité antimicrobienne qui comprend un acide aminé N-halogéné et un agent de transfert de phase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

N-halogenated amino acid formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-halogenated amino acid formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-halogenated amino acid formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1476033

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.